RT @ICONplc: This #publication provides insights into the individual reasons for non-adherence to oral methotrexate treatment in #RA patien…
This #publication provides insights into the individual reasons for non-adherence to oral methotrexate treatment in #RA patients. https://t.co/M5KJl10boT #rheumatoidarthritis https://t.co/SLHXTMvR7x
RT @ICONplc: Adherence to disease-modifying anti-rheumatic drugs is suspected to be highly variable potentially leading to reduced treatmen…
Adherence to disease-modifying anti-rheumatic drugs is suspected to be highly variable potentially leading to reduced treatment effectiveness. Read the #publication. https://t.co/EIcBl1LbRS #rheumatoidarthritis https://t.co/vj6XBUi2rs
A case study on a multi-partner approach which powered impressive study recruitment and completion rates in the METNA RA study – a cross sectional survey to validate a new methotrexate adherence tool in patients with rheumatoid arthritis. Link: https://t
RT @JPRO_ISOQOL: Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool…
Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis https://t.co/ubfZY1TEkZ